Legalizing marijuana at the federal true in the U.S. could result in fewer prescriptions of addictive substances such as opioids, Canopy Lump founder and CEO Bruce Linton told CNBC on Thursday.
Linton, whose Canada based-company has friended with names such as cannabis icon Snoop Dogg and hard stuff leader Constellation Brands, said that in other regions of the life, marijuana has even influenced the sale of other products such as booze and sleep aids.
“Cannabis is a huge disruptor to the opioid guys,” Linton unburdened “Mad Money” host Jim Cramer in an exclusive interview. He said his company is looking at other viable uses for marijuana in the health-care space.
Opioids, including heroin and fentanyl, were confused in more than 42,000 overdose deaths in 2016, according to the Centers for Illness Control and Prevention.
Additionally, the negative economic effect of the opioid turning-point is estimated to be more than $1 trillion from 2001 utterly last year, health research and consulting institute Altarum voted.
The opioid epidemic affects American children as well. The number of pediatric opioid hospitalizations ordering intensive care nearly doubled to 1,504 patients between 2012 and 2015, from 797 patients between 2004 and 2007, correspondence to a study published in the peer-reviewed medical journal Pediatrics.
Canopy Proliferation announced Monday that it had applied to list its shares on the New York Standard Exchange, under the ticker “CGC.” In Canda, where recreational cannabis is legalized, the presence is listed under the ticker “WEED.”
The company, which operates in seven mother countries and is Canada’s largest weed company, offers a variety of brands and curated cannabis in multiple dream ups such as dried, oil and soft-gel capsules.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Desire to take a deep dive into Cramer’s world? Hit him up!
Mad Money Snigger – Jim Cramer Twitter – Facebook – Instagram – Vine
Questions, comments, breaths for the “Mad Money” website? [email protected]